Evolva logo — company profile

Evolva

Founded 2004 Switzerland Reinach, Switzerland 74 employees Grant Total: $102.54M Biotechnology, Food and Beverage +2

General Information

Company Name Evolva
Founded Year 2004
Location Switzerland Reinach, Switzerland
Founders / Decision Makers
Team member
Employees 74
Industries Biotechnology, Food and Beverage, Health Care +1
Funding Stage Grant
Business Model B2B
Revenue Model Product Sales, One Time Purchase, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Evolva. To contact Evolva, visit evolva.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Evolva

Evolva, founded in 2004 and headquartered in Switzerland, is positioned at the intersection of Biotechnology, Food and Beverage, Health Care, and Health and Wellness. The company utilizes advanced technology platforms, such as fermentation, to address sourcing challenges in nature. This innovative approach allows Evolva to produce high-quality ingredients that are consistently available and based on nature, catering to health, wellbeing, and sensory experiences.

With a diverse team of approximately 55 employees representing 15 nationalities, Evolva fosters an interdisciplinary and inclusive work environment. The company's commitment to research and commercialization ensures the availability of affordable and ready-to-formulate products. Notably, their latest financial backing was a $540.00K grant investment from the Centers for Disease Control and Prevention in October 2022, underlining a strong endorsement from a reputable entity. Investors should consider Evolva’s potential for continued growth and impact within its sectors.

Taxonomy: Nutrition, Health, Wellness, Ingredients, Synthetic Biology, Fermentation, Technology Platform, Small-Molecule Drugs, Natural Products, Sweetener, Flavors and Fragrances, Science, Biology, Sensory Enjoyment

Services & Products

product development
innovation in flavors and fragrances
sustainable ingredient sourcing
corporate communication

Target Customers

investors shareholders business partners consumers interested in sustainable products

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $540.00K 1
Centers for Disease Control and Prevention
21 Oct 2022
Post IPO Equity Fr.6.30M -
23 May 2022
Post IPO Debt Fr.12.00M 1
Nice & Green SA
27 Dec 2021
Post IPO Equity Fr.12.00M 1
Nice & Green SA
08 Dec 2020
Series B Fr.16.00M 9
Swisscom Ventures, Novartis Venture Fund +7
11 Dec 2009
Series B Fr.28.00M 8
Novartis Venture Fund, Auriga Partners +6
22 Oct 2009
Grant €3.40M -
01 Jan 2008
Series A $10.30M 5
Novartis Venture Fund, Aravis +3
01 Dec 2006
Series A €2.00M 4
Novartis Venture Fund, APIDC Venture Capital +2
21 Mar 2005
Series A €12.00M 4
Novartis Venture Fund, Aravis +2
16 Aug 2004

Evolva Alternatives & Competitors

View All Alternatives
Evolva vs
Manus
Manus United States

Accelerating the Transition to BioAlternatives

Grant
150 employees
Biopharma, Biotechnology
Evolva vs

Curing the food system one protein at a time. 1st product is a sugar substitute that is a sustainab...

Venture round
51 employees
Biotechnology, Food and Beverage
Evolva vs
Geltor
Geltor United States

Geltor is the biodesign company powering the products of the future with effective, sustainable, ani...

19 employees
Biotechnology, Food and Beverage

FAQ About Evolva

At Evolva we believe in applying technology platforms, such as fermentation, to help resolve sourcing bottlenecks in nature. These enable us to provide products that can contribute to health, wellbeing and sensory enjoyment. We research, develop and commercialize high quality, affordable, ready-to-f...
Evolva was founded in 2004.
Evolva is headquartered in Reinach, Switzerland.
Evolva operates in Biotechnology, Food and Beverage, Health Care and Health and Wellness. Its work centres on Nutrition, Health, Wellness and Ingredients. Its customers include investors, shareholders and business partners.
Evolva has a B2B business model. Its revenue comes from Product Sales, One Time Purchase and Tiered Pricing.
Evolva has approximately 74 employees.
Evolva has completed 10 funding rounds, raising a total of $102.54M. The latest funding stage is Grant.
Evolva offers: product development, innovation in flavors and fragrances, sustainable ingredient sourcing, corporate communication.
Top alternatives and competitors to Evolva include Manus, Amai Proteins, Geltor, michroma, TurtleTree. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Evolva and Manus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Evolva, https://bouncewatch.com/company/evolva, updated 30 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes